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Purpose: To determine whether curcumin induces expression of the defensive enzyme heme oxygenase-1 (HO-1) and
protects cells against oxidative stress in cultured human retinal pigment epithelial cells.
Methods: Effective concentrations and toxicities of curcumin were determined after 3 h of curcumin treatment with the
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Confluent human retinal pigment epithelium cell
lines  (ARPE-19)  were  preincubated  with  curcumin  and  oxidatively  challenged  with  H2O2.  HO-1  expression  was
determined with western blot analysis. To confirm the protective role of HO-1 in oxidative stress, small interfering RNA
(siRNA) against HO-1 or inhibitor of HO-1 was treated with curcumin in retinal pigment epithelium cells. Intracellular
levels of reactive oxygen species (ROS) were measured with flow cytometry and confocal microscopy. Apoptosis was
evaluated with Annexin V-fluoroscein isothiocyanate staining.
Results: Curcumin had little cytotoxicity at concentrations less than 30 μM, and HO-1 expression was the highest at the
15 μM concentration. At this concentration, curcumin also increased the cytoprotective effect against the oxidative stress
of H2O2 through the reduction of ROS levels in human retinal pigment epithelial cells. Curcumin’s effect on the reduction
of ROS was mediated by the increase in HO-1 expression.
Conclusions: Curcumin upregulated the oxidative stress defense enzyme HO-1 and may protect human retinal pigment
epithelial cells against oxidative stress by reducing ROS levels.
Age-related macular degeneration (AMD) is the most
common cause of blindness in patients aged 65 or over in the
Western world [1], and incidence continues to rise as a result
of the increasing percentage of older adults in the general
population. Pathologically, AMD results from retinal pigment
epithelium  (RPE)  dysfunction  or  loss  associated  with
photoreceptor  fallout,  Bruch’s  membrane  thickening,  and
choriocapillary hypoperfusion [2]. The RPE is a monolayer
of pigmented cells forming part of the blood retina barrier and
is particularly susceptible to oxidative stress because of the
layer’s high consumption of oxygen. Thus, chronic oxidative
stress induces RPE damage that is responsible for the aging
process  and  may  therefore  play  an  important  role  in  the
pathogenesis  of  AMD  [3,4].  Human  RPE  has  many
antioxidative enzymes such as superoxide dismutase, heme
oxygenase, and enzymes involved in glutathione synthesis
[5,6]. Heme oxygenase-1 (HO-1) is a ubiquitous and redox-
sensitive  inducible  stress  protein  known  to  protect  cells
against various types of stress. The importance of this protein
in physiologic and pathological states is underlined by the
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versatility  of  HO-1  inducers  and  the  protective  effects
attributed  to  heme  oxygenase  byproducts  in  conditions
associated with moderate or severe cellular stress [7,8].
Curcumin, a biologically active component of turmeric,
which  has  been  used  in  India  for  medical  purposes  for
centuries,  has  a  variety  of  pharmacological  activities,
including  antioxidant,  anti-inflammatory,  and
antiproliferative effects. Curcumin is an effective scavenger
of reactive oxygen species in vitro and indirectly enhances the
synthesis of antioxidative enzymes [9,10]. In this study, we
hypothesized that curcumin has cytoprotective effects with
HO-1 expression against H2O2 oxidative stress in cultured
human retinal pigment epithelial cells.
METHODS
Materials:  Curcumin,  H2O2,  zinc  protoporphyrin  (ZnPP;
HO-1  inhibitor),  cobalt  protoporphyrin  (CoPP;  HO-1
stimulator),  and  SB  203580  were  purchased  from  Sigma
Aldrich  (St.  Louis,  MO).  3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium  bromide  (MTT)  and  2’7’-
dichlorodihydro-fluorescein  diacetate  (H2DCFDA)  were
obtained from Invitrogen Molecular Probes, Inc. (Carlsbad,
CA).
Cell culture: ARPE-19 cells originated from human retinal
pigment epithelial cells. The ARPE cells were purchased from
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901the American Type Culture Collection (ATCC, Manassas,
VA). RPE cells were cultured in T-75 flasks with Dulbecco’s
modified  Eagle’s  medium  (Invitrogen)  supplemented  with
10% fetal bovine serum (FBS; Sigma, St. Louis, MO) and 100
U⁄ml penicillin and streptomycin (Gibco-BRL, Gaithersburg,
MD). During incubation, the culture medium was changed
every 2 days. All cultures were maintained at 37 °C under 5%
CO2 with 95% relative humidity.
Cell  viability  assay  (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide assay): The MTT assay was
used to determine cell viability. Briefly, cells grown in 96-
well plates were washed twice with Phosphate buffer solution
(PBS;  1.54  mM  KH2PO4,155.17  mM  NaCl,  2.71  mM
Na2HPO4-7H2O)  and  replaced  with  culture  medium
containing 0.5 μl/ml MTT. After 4 h incubation with MTT
solution, medium was carefully removed from the plate, and
isopropanol was added to solubilize formazan produced from
MTT by viable RPE cells. The absorbance at 540 nm was
measured  using  a  microplate  reader  (Spectromax  190;
Molecular Devices Corp., Sunnyvale, CA).
Western blot analysis: Western blot analysis was used to
evaluate HO-1 expression. Cells grown in 6-well plates were
washed with PBS twice and replaced with 1 ml of PBS. After
RPE cells were harvested on the floor of the plate, cells were
lysed  using  RIPA  buffer  (Sigma)  supplemented  with  a
protease  inhibitor  cocktail  (Roche,  Indianapolis,  IN).  Cell
lysates  were  centrifuged  at  13,000×  g  for  15  min,  and
bicinchoninic (BCA) protein assay (Pierce, Rockford, IL) was
used to determine the protein concentrations of the extracted
solutions. Protein concentration was determined with BCA
assay. The sample (10 μg protein) was loaded in 10% sodium
dodecyl  sulfate  PAGE  gel.  Gel  proteins  were
electrophoretically  transferred  to  a  poly  (vinylidene
difluoride)  membrane  (Thermo  Scientific,  Rockford,  IL).
Membranes were blocked with 3% non-fat dried milk in PBS,
and then probed with a polyclonal rabbit anti-HO-1 antibody
(1:100 dilution in Tris-buffered saline, pH 7.4) overnight in a
dark cold room. After three washings with PBS containing
0.05% (v/v) Tween-20, the blots were visualized using an
amplified alkaline phosphatase kit from Sigma.
Transfection  of  single  interfering  RNAs:  RPE  cells  were
transfected  with  double-stranded  single  interfering  RNAs
(siRNAs; 50 nmol/ml) against HO-1 (Qiagen, Valencia, CA:
target sequence, 5′-CAG GCA ATG GCC TAA ACT TCA-3′
Hs_HMOX1_5)  for  12  h  with  the  Lipofectamine  method
according  to  the  manufacturer’s  protocol  (Invitrogen,
Carlsbad, CA) and recovered in fresh media containing 10%
FBS for 12 h. In brief, after combination 2 µg DNA in 100 µl
OPTI-MEM and 6 µl Lipofectamine in 100 µl OPTI-MEM,
the mixture was incubated at room temperature for 30min and
then overlaid the cells. HO-1 expression interference was
confirmed  with  immunoblot  using  anti-HO-1  antibodies;
scrambled siRNA was used as a control.
Determination of intracellular reactive oxygen species levels:
ROS  levels  were  measured  using  2’7’-dichlorodihydro-
fluorescein  diacetate  (carboxy-H2DCFDA),  which  is
converted  into  a  non-fluorescent  derivative  (carboxy-
H2DCF)  by  intracellular  esterases.  Carboxy-H2DCF  is
membrane  impermeant  oxidized  to  fluorescent  derivative
carboxy-DCF  by  intracellular  ROS.  After  the  indicated
treatments, cells were washed with PBS and incubated with
PBS containing 10 μM carboxy-H2DCFDA for 20 min at
37 °C. Loading buffer was removed, and a short recovery time
was  allowed  for  the  cellular  esterases  to  hydrolyze  the
acetoxymethyl ester or acetate groups and render the dye
responsive  to  oxidation.  Then  the  cells  were  returned  to
prewarmed growth medium and incubated for 20 min at 37 °C.
Cells were washed twice with PBS, trypsinized, and collected
in 1 ml PBS. Cells were then transferred to polystyrene tubes
with cell-strainer caps (Falcon, Becton Dickinson, Franklin
Lakes, NJ) and analyzed with flow cytometry. Geometric
distributions of carboxy-DCF fluorescence were calculated
using FACS (FACScan; Becton Dickinson) and Cell Quest
3.2 (Becton Dickinson) software for acquisition and analysis.
Green ROS fluorescence was visualized using an Olympus
(Tokyo,  Japan)Flouview-FV300  Laser  Scanning  Confocal
system.
Annexin  V-fluoroscein  isothiocyanate  staining  to  evaluate
apoptosis:  Following  experimental  treatments,  cells  were
centrifuged at 1,000× g for 5 min and the pellets were washed
twice with 1.0 ml cold PBS and 1.0 ml cold binding buffer
(10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, and 2.5 mM
CaCl2). Cells were resuspended in 100 μl of binding buffer
and stained with 2 μl of Annexin V-fluoroscein isothiocyanate
(V-FITC) solution and 10 μl propidium iodide (PI) solution
for 15 min at room temperature in the dark. Samples were then
diluted with 400 μl binding buffer and analyzed with flow
cytometry within 30 min. A minimum of 50,000 cells were
maintained for all samples. Samples were analyzed with a
FACScalibur  flow  cytometer  (BD  Biosciences,
Erembodegem, Belgium).
RESULTS
Effect of curcumin on cytotoxicity in human retinal pigment
epithelial  cells:  To  evaluate  cell  viability  in  different
concentrations of curcumin and determine its non-cytotoxic
concentration,  curcumin  dissolved  in  dimethyl  sulfoxide
(DMSO) was mixed with variable concentrations of culture
medium. RPE cells were plated onto 96-well plates at a density
of 2×104/well, and each well contained 200 μl culture medium.
After 24 h incubation, RPE cells were incubated with different
concentrations of curcumin-containing cell medium for 3 h.
Cell viability was measured with the MTT assay. The
non-treated  and  curcumin-treated  groups  showed  no
significant difference in cell viability (Figure 1A).
Effect of curcumin on heme oxygenase-1 expression in human
retinal pigment epithelial cells: To evaluate HO-1 expression
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902of RPE cells under curcumin treatment, RPE cells were plated
onto 96-well plates at a density of 3×105/well. After 24 h
incubation,  cell  medium  was  exchanged  with  curcumin-
containing  cell  medium  and  incubated  for  3  h.  HO-1
expression was evaluated with western blot analysis. HO-1
expression in RPE cells was highest at the 15 μM curcumin
concentration (Figure 1B).
Cell viability of human retinal pigment epithelial cells under
oxidative stress by H2O2: To evaluate cell viability in different
H2O2 concentrations, H2O2 was mixed with culture medium.
RPE cells were plated onto 96-well plates at a density of
2×104/well, and each well contained 200 μl of culture medium.
After  24  h  incubation,  cell  medium  was  exchanged  with
H2O2-containing cell medium of different concentrations, and
cells were incubated for 24 h. Cell viability was measured with
MTT assay. Concentrations of less than 500 μM H2O2 showed
no  significant  difference  in  cell  viability;  however,  in
concentrations of more than 500 μM H2O2, dose-dependent
RPE cell death was observed (Figure 2).
Protective effect of curcumin on retinal pigment epithelial
cells  against  H2O2-induced  oxidative  stress  via  heme
oxygenase-1 expression: RPE cells in 96-well plates were
incubated for 24 h and pretreated with 15 μM curcumin for 3
Figure 1. Cell viability and heme oxygenase-1 (HO-1) expression in
human retinal pigment epithelial cells (ARPE-19) with different
concentrations  of  curcumin-containing  medium.  ARPE-19  cells
were exposed to various concentrations of curcumin for 3 h. Cell
viability (A) was measured with 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium  bromide  (MTT)  assay  and  HO-1  protein
expression (B) was measured with western blot analysis. The non-
treated  and  curcumin-treated  groups  showed  no  significant
difference in cell viability, and HO-1 expression was highest in 15
μM curcumin.
h.  Each  well  was  then  washed  with  PBS,  and  different
concentrations of H2O2 (0, 500, and 1,000 μM) were added for
an additional 3 h. Cell viability was measured with the MTT
assay,  and  HO-1  protein  expression  was  measured  with
western  blot  analysis.  Curcumin  pretreatment  showed  a
cytoprotective effect against H2O2 oxidative stress in RPE
cells. Cell viability in the curcumin-pretreatment group was
higher  than  in  the  control  DMSO  group.  At  higher  H2O2
concentrations, cell viability decreased dose-dependently as
in the previous results. At the 1,000 μM H2O2 concentration,
the curcumin-pretreatment and control DMSO groups showed
the greatest significant difference in cell viability (Figure 3A).
HO-1 expression in the curcumin-pretreatment group was
higher than in the control group (Figure 3B).
Effect of curcumin on reactive oxygen species reduction via
stimulating heme oxygenase-1 expression: RPE cells were
plated onto 12-well plates at a density of 3×105/well, and each
well  contained  2  ml  of  culture  medium.  After  1  day  of
incubation, some cells were pretreated with either DMSO,
15 μM curcumin, or 10 μM CoPP (as an HO-1 stimulator) for
3 h, and other cells were pretreated with 10 μM ZnPP (as an
HO-1 inhibitor) for 1 h and 15 μM curcumin for 3 h. After
different pretreatments, all cells were treated with 1,000 μM
H2O2  for  3  h.  ROS  levels  were  determined  using  10  μM
carboxy-H2DCFDA  with  flow  cytometry  and  confocal
microscopy. In the cytometry fluorescence histograms, H2O2
caused the ROS levels to increase compared to the control
Figure 2. Cell viability in human retinal pigment epithelial cells with
different concentrations of H2O2-containing medium. Human retinal
pigment epithelial cells (ARPE-19) cells were exposed to various
concentrations of H2O2 for 3 h. Cell viability was measured with 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay. No significant difference in cell viability was observed in
doses of less than 500 μM H2O2. However, doses above 500 μM
H2O2 caused dose-dependent retinal pigment epithelium (RPE) cell
death. **p<0.01, ***p<0.001. Histograms are representative of three
independent experiments. Each bar represents mean±SD (standard
deviation) from three independent experiments.
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903group. At the 1,000 μM H2O2 concentration, 15 μM curcumin
reduced ROS levels compared with DMSO. The result for
10 μM CoPP as an HO-1 stimulator was similar to that for
15  μM  curcumin.  Pretreatment  with  ZnPP  reversed
curcumin’s reduction of ROS. These findings suggest that
curcumin  reduces  ROS  levels  by  stimulating  oxidative
defense enzyme production such as HO-1 (Figure 4A,B). In
confocal microscopy, the extent of staining in the 1,000 μM
H2O2–treated group appeared to be greater than in the control
group. ROS levels in the 15 μM curcumin–treated group or
10  μM  CoPP–treated  group  appeared  lower  than  in  the
1,000  μM  H2O2–treated  group.  The  results  from  confocal
microscopy were similar to the findings from of the cytometry
Figure 3. Cell viability and heme oxygenase-1 (HO-1) expression in
human  retinal  pigment  epithelial  cells  between  curcumin
pretreatment and control dimethyl sulfoxide (DMSO) groups with
various H2O2 concentrations. A: Cell viability measured with 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium  bromide  (MTT)
assay.  Human  retinal  pigment  epithelial  cells  (ARPE-19)  cells
pretreated with 15 μM curcumin showed more cell viability than
those from the control DMSO group. The difference was highest in
1000 μM H2O2. *p<0.05 . The percentage of live cells among the
total cells was calculated from three separate experiments. B: HO-1
protein expression was measured with western blot analysis. The plus
sign means pretreatment with 15 μM curcumin. HO-1 expression was
higher in the curcumin-pretreated group under treatment of H2O2
compared to the control group. β-actin served as the standard. Results
were quantified with densitometry. The image for HO-1 was shown
from more than three separate experiments.
analysis (Figure 5). To evaluate apoptosis under the same
conditions as ROS measurement, Annexin V/PI staining and
flow  cytometry  were  used.  As  expected,  the  effects  of
curcumin on H2O2-induced apoptosis corresponded with the
ROS measurement (Figure 6A,B). To further confirm the
inhibitory effect of curcumin on apoptosis via HO-1, RPE
cells were transfected with siRNA.
As shown in Figure 7, in the absence of HO-1, curcumin
could not suppress H2O2-induced apoptosis. Therefore, we
suggest HO-1 induced by curcumin plays an important role in
H2O2-induced  apoptosis  in  RPE  cells.  In  an  effort  to
understand the possible mechanism(s) responsible for HO-1
expression and reduction of apoptosis by curcumin in RPE
Figure 4. Effect of curcumin on intracellular reactive oxygen species
(ROS)  levels.  Retinal  pigment  epithelium  (RPE)  cells  were
separately pretreated with 15 µM curcumin and 10 µM CoPP known
as heme oxygenase-1 (HO-1) stimulator for 3 h. About 10 µM ZnPP,
a known HO-1 inhibitor, was added to cells preprocessed for 1 h after
2 h pretreatment with 15 µM curcumin. Cells were then treated with
1000 µM H2O2 for 3 h. Intracellular ROS levels in RPE cells were
measured  with  flow  cytometry  (see  Materials  and  Methods).  In
contrast, ROS levels were increased (shift in relative fluorescence
intensity) in cells cotreated with curcumin and ZnPP. A: (a) dimethyl
sulfoxide (DMSO), (b) DMSO + H2O2, (c) curcumin (15 µM) +
H2O2, (d) curcumin (15 µM) + H2O2 +ZnPP (10 µM), (e) CoPP (10
µM) + H2O2. B: Columns, percentage of DCF-CA-stained cells for
indicated conditions. Each bar represents the mean±SD of three
independent experiments (**p<0.01, ***p<0.001)
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activation. Activation of p38 was increased by curcumin in a
time-dependent  manner  (Figure  8A).  Inhibition  of  p38
significantly reduced the protective effect of curcumin against
H2O2-induced death (Figure 8B).
DISCUSSION
Aging has been defined as the progressive accumulation of
changes with time associated with or responsible for ever-
increasing susceptibility to disease and death. The free radical
theory of aging proposes that aging and age-related disorders
are the result of cumulative damage arising from reactions
involving  ROS.  ROS  cause  oxidative  damage  to  cell
cytoplasmic and nuclear elements and cause changes to the
extracellular  matrix  [11,12].  The  retina  is  particularly
susceptible to oxidative stress because of its high consumption
of oxygen. The role of oxidative stress in the pathogenesis of
AMD is biologically important. Much of the research into the
relationship between oxidative stress and AMD has supported
the hypothesis that there is a link between oxidative events
and the onset of AMD [3,4,13]. Human studies show that
dietary intake and supplementation with antioxidants, such as
glutathione,  vitamin  C,  superoxide  dismutase,  catalase,
vitamin E, carotenoids, and zinc, are associated with reduced
risk of AMD [14,15]. Other studies show that flavonoids
commonly found in fruit and vegetables provide short- and
Figure 5. Effect of curcumin on reactive oxygen species (ROS)
generation in retinal pigment epithelium (RPE) cells. Cells were
separately pretreated with curcumin (15 μM) and CoPP as a heme
oxygenase-1 (HO-1) activator for 3 h and then treated with 1000
μM H2O2 for 3 h. ROS levels treated with curcumin and those treated
with  CoPP  decreased  at  a  similar  rate.  To  quantify  cells  with
increased intracellular ROS levels, the percentages of fluorescent
cells among the total cells were calculated and the means± SD were
expressed from three separate experiments. *p<0.05, **p<0.01.
long-term protection, and long-term protection is associated
with phase-2 proteins such as glutathione metabolism and
HO-1 [16].
Curcumin,  the  natural  yellow  pigment  phenolic
compound  contained  in  turmeric  and  isolated  from  the
Figure 6. Effect of curcumin on H2O2-induced apoptosis. Retinal
pigment  epithelium  (RPE)  cells  were  pretreated  with  15  µM
curcumin and 10 µM CoPP for 3 h. About 10 µM ZnPP was added
to cells preprocessed for 1 h after 2 h pretreatment with 15 µM
curcumin. Cells were then treated with 1000 µM H2O2 for 3 h.
Apoptotic cells were detected with Annexin V-FITC staining and
analyzed with flow cytometry. A: (a) dimethyl sulfoxide (DMSO),
(b) DMSO + H2O2, (c) curcumin (15 µM) + H2O2, (d) curcumin (15
µM) + H2O2 +ZnPP (10 µM), (e) CoPP (10 µM) + H2O2. B: Columns,
percentage of Annexin V positive cells for indicated conditions. Each
bar  represents  the  mean±SD  of  three  independent  experiments
(*p<0.05)
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as  the  most  active  constituent  of  turmeric  [17].  In  the
Ayurvedic system of medicine, turmeric is used as a tonic and
blood purifier. Its role in skin disease treatment and its ability
to soften rough skin resulted in prolific use in topical creams
and  bath  soaps  in  India.  Turmeric’s  use  as  an  anti-
inflammatory and antimicrobial agent has been recognized for
more than a century [18,19]. Several animal studies have
shown that curcumin used in painting colors and flavoring in
food possesses anti-inflammatory and antioxidant properties
and affords protection against chemical carcinogen-induced
tumorigenesis in skin, colon, stomach, duodenal, lung, and
prostate cancer [20,21].
Particularly,  curcumin  exhibits  strong  antioxidant
activity comparable to vitamins C and E. Curcumin is a potent
scavenger  of  ROS,  including  superoxide  anion  radicals,
hydroxyl radicals, and ROS, in in vitro studies [9,10]. In
addition to direct antioxidant activity, curcumin may function
Figure 7. Involvement of heme oxygenase-1 (HO-1) in H2O2-induced
apoptosis in retinal pigment epithelium (RPE) cells. Human RPE
cells were transfected with control single interfering RNA (siRNA)
or HO-1 siRNA. After being pretreated with 15 μM curcumin for 3
h, cells were treated with 1000 µM of H2O2 for 3 h. A: Transfection
with siRNA against HO-1 caused reduction in HO-1 expression. The
expression levels of HO-1 were determined by Western immunoblot
analysis B: Apoptotic cells were detected with Annexin V-FITC
staining  and  analyzed  with  flow  cytometry.  Histograms  are
representative of three independent experiments. Each bar represents
mean±SD (standard deviation) from three independent experiments.
*p<0.05.
indirectly  as  an  antioxidant  by  enhancing  antioxidant
enzymes, such as heme oxygenase, glutathione peroxidase,
glutathione reductase, catalase, and phase-2 enzymes such as
glutathione  S  transferase  and  quinone  reductase  [22-25].
HO-1 and glutathione S transferase are found in the human
retina and can be a defense against oxidative stress. In AMD,
the ability to upregulate HO-1 and glutathione S transferase
diminishes; as a consequence, oxidative stress increases in
human RPE.
HO-1 is the rate-limiting first step in heme catabolism
that degrades heme to carbon monoxide (CO), free Fe2+, and
biliverdin that is further converted to the antioxidant bilirubin
by biliverdin reductase [26,27]. Bilirubin also modulates cell
signal transduction pathways relevant to inflammation. Free
Fe2+ rapidly induces ferritin expression and the ATPase Fe2+-
Figure 8. Role of p38 activation in induction of heme oxygenase-1
(HO-1) by curcumin. A: Retinal pigment epithelium (RPE) cells
were  treated  with  15  μM  curcumin  at  the  indicated  time  point.
Phosphorylated  p38  and  p38  levels  were  detected  with  western
blotting. B: RPE cells were pretreated with 15 µM curcumin and 10
µM CoPP for 3 h. About 10 µM ZnPP or 20 µM SB203580 as a p38
inhibitor  was  added  to  cells  preprocessed  for  1  h  after  2  h
pretreatment with 15 µM curcumin. Cells were then treated with
1000 µM H2O2 for 3 h. Cell viability was determined with 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium  bromide  (MTT)
assay. Data are expressed as mean±SEM from four independent
experiments. *p<0.05, **p<0.01, ***p<0.001.
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906secreting pump to decrease Fe2+, thereby limiting oxidative
damage created via the Fenton reaction. CO, the third product
of HO-1 activity, stimulates cell signaling similar to nitric
oxide, but absent its radical activity [28-32]. CO mediates
vasodilatation, inhibits platelet aggregation, and suppresses
cytokine  production—all  factors  associated  with  the
amelioration  of  AMD  pathophysiology.  Thus,  HO-1
induction may confer protection in the retina by increasing
resistance to oxidative stress, inflammation, and apoptosis.
Curcumin at higher doses is cytotoxic but at lower doses
can exert an adaptive stress response. A pretreatment dose of
20 μM for more than 24 h can induce cell death, but we used
doses of 15 μM curcumin for only 3 h, which is below the
cytotoxic level. About 15 μM curcumin induced the most
HO-1  expression,  reduced  ROS  via  HO-1,  and  exerted
significant protection against increasing doses of H2O2. We
propose that p38 activity is important in the signal mechanism
for induction of HO-1 by curcumin in RPE cells (Figure 8B).
The  proposed  mechanism  is  consistent  with  experiments
performed using the garlic extract diallyl sulfide as an HO-1
inducer [33,34].
In vivo models and human clinical trials of high-dose
curcumin  consumption  confirmed  the  lack  of  significant
toxicity and adverse effects [35-38]. However, absorption,
biodistribution,  metabolism,  and  elimination  studies  of
curcumin have unfortunately shown only poor absorption,
rapid metabolism, and elimination, which represent the low
oral bioavailability of this interesting polyphenolic compound
[39-42]. Nevertheless, curcumin is known to pass through the
blood-brain barrier, and dietary curcumin was found to be
effective against forebrain ischemia and traumatic brain injury
in animal models. Furthermore, dietary curcumin has been
associated with reduced expression of oxidative stress and
inflammation markers in the cerebral cortex in a transgenic
mouse model of Alzheimer disease [43].
Recently, dietary supplementation of curcumin has been
shown to be effective in modulating redox status in a rat model
of  streptozotocin-induced  diabetic  retinopathy  and  retinal
neuroprotection  using  an  in  vivo  model  of  light-induced
retinal degeneration in rats [44,45].
We do not know how much diet-supplemented curcumin
reaches the human retina. However, according to recent use
of flavonoids and anthocyanins that express HO-1 for AMD,
we believe that curcumin, a strong HO-1 inducer, is a good
antioxidant for preventive and augmentative therapy of AMD.
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